Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas

NCT06660810 is registered in ClinicalTrials.gov with John Rieth as lead sponsor.

NCT NCT06660810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06660810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Lead sponsor
John Rieth
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 3, 2025
Completion date
February 24, 2031
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma,soft tissue, soft tissue sarcoma